Obesity D009765

Description

A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).   MeSH

Subtype Terms (7)

Obesity, Abdominal
67 drugs (25 approved, 42 experimental)

Obesity Hypoventilation Syndrome
1 approved drug

Obesity, Maternal
1 approved drug

Obesity, Metabolically Benign
2 drugs (1 approved, 1 experimental)

Obesity, Morbid
82 drugs (67 approved, 15 experimental)

Pediatric Obesity
60 drugs (26 approved, 34 experimental)

Prader-Willi Syndrome
26 drugs (14 approved, 12 experimental)


Phase 4 Indicated Drugs (165)

Phase 2 Indicated Drugs (135)

Other Experimental Indicated Drugs (344)


Organization Involved with Phase 4 Indications (103)

Organization Involved with Phase 3 Indications (72)

Organization Involved with Phase 2 Indications (95)

Organization Involved with Other Experimental Indications (127)

Hierarchy Tree View

UMLS Data


YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.